Differential allelic distribution of V-ets erythroblastosis virus E26 oncogene homolog2 (ETS2) functional polymorphisms in different group of patients

Gene Expression

Volumn 15, Issue 2, 2011, Pages 61-73

  Chatterjee, Arpita ^a   Dutta, Samikshan ^a,f   Mukherjee, Sanjit ^b   Mukherjee, Nupur ^c   Chandra, Sharmila ^d   Mukherjee, Ashis ^e   Sinha, Swagata ^a   Panda, Chinmay Kumar ^c   Chaudhuri, Keya ^b   Mukhopadyay, Kanchan ^a  

^a Manovikas Biomedical Research and Diagnostic Centre   (India)

^b INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^c CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^d Research Institute   (India)

^e Netaji Subhash Chandra Bose Cancer Research Institute   (India)

^f Dongguk University College of Medicine   (South Korea)

Author keywords

Acute lymphoblastic leukemia (ALL); Breast cancer; Down's syndrome; Oral cancer; rs1051420; rs1051425; rs457705; rs461155

Indexed keywords

TRANSCRIPTION FACTOR ETS 2;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BREAST CANCER; CHILD; COMPUTER MODEL; CONTROLLED STUDY; DNA BASE COMPOSITION; DOWN SYNDROME; FEMALE; GENE FREQUENCY; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE OVEREXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALGORITHMS; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; COMPUTATIONAL BIOLOGY; DOWN SYNDROME; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; INDIA; LEUKEMIA; LINKAGE DISEQUILIBRIUM; MALE; MOLECULAR SEQUENCE DATA; PATIENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEIN C-ETS-2;

EID: 79955153542     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: 10.3727/105221611X12973615737541     Document Type: Article

References (33)

1. Baker, K. M.; Wei, G.; Schaffner, A. E.; Ostrowski, M. C. Ets-2 and Components of mammalian SWI/SNF form a repressor complex that negatively regulates the BRCA1 promoter. J. Biol. Chem. 278:17876-17884; 2003.
2. Baker, S. G.; Kramer, B. S. Paradoxes in carcinogenesis: New opportunities for research directions. BMC Cancer 7:151; 2007.
3. Bengert, P.; Dandekar, T. A software tool-box for analysis of regulatory RNA elements. Nucl. Acids Res. 31:3441-3445; 2003.
4. Beyer, K.; Dandekar, T.; Keller, W. RNA ligands selected by cleavage stimulation factor contain distinct sequence motifs that function as downstream elements in 3′-end processing of pre-mRNA. J. Biol. Chem. 272: 26769-26779; 1997.
5. Buggy, Y.; Maguire, T. M.; McDermott, E.; Hill, A. D.; O'Higgins, N.; Duffy, M. J. Ets2 transcription factor in normal and neoplastic human breast tissue. Eur. J. Cancer 42:485-491; 2006.
6. Carbone, G. M.; Napoli, S. Triplex DNA-mediated downregulation of Ets2 expression results in growth inhibition and apoptosis in human prostate cancer cells. Nucl. Acids Res. 32:4358-4367; 2004.
7. Chatterjee, A.; Mukherjee, N.; Panda, C. K.; Mukhopadhyay, K. Could allelic discrimination in ETS2 predispose individuals to breast cancer? Open Breast Cancer J. 2:1-3; 2010.
8. Conde, L.; Vaquerizas, J. M.; Dopazo, H.; Arbiza, L.; Reumers, J.; Rousseau, F.; et al. PupaSuite: Finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucl. Acids Res. 34: W621-625; 2006.
9. Corpet, F. Multiple sequence alignment with hierarchical clustering. Nucl. Acids Res. 16(22):10881-10890; 1988.
10. Dudbridge, F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25(2):115-121; 2003.
11. Finch, J. T.; Perutz, M. F.; Bertles, J. F.; Doblert, J. Structure of sickled erythrocytes and of sickle-cell hemoglobin fibers. Proc. Natl. Acad. Sci. USA 70:718-722; 1973.
12. Hariharan, M.; Scaria, V.; Brahmachari, S. K. dbSMR: A novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinformatics 10: 108; 2009.
13. Hasle, H.; Clemmensen, I. H.; Mikkelsen, M. Risks of leukemia and solid tumors in individuals with Down's syndrome. Lancet 355:165-169; 2000.
14. Huang, C. S.; Shen, C. Y.; Wang, H. W.; Wu, P. E.; Cheng, C. W. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer. Clin. Chim. Acta 384:69-74; 2007.
15. Kim, B. C.; Kim, W. Y.; Park, D.; Chung, W. H.; Shin, K.; Bhak, J. SNP@Promoter: A database of human SNPs single nucleotide polymorphisms within the putative promoter regions. BMC Bioinformatics 9(Suppl. 1):S2; 2008.
16. Kumar, P.; Henikoff, S.; Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nature Protocols 4: 1073-1082; 2009.
17. Lee, I. K.; Choi, J. H.; Kim, Y. K.; Kim, H. N.; Park, K. S.; Lee, J. J.; et al. Two single nucleotide polymorphisms of the ETS2 transcriptional factor gene predispose individuals to high-risk acute myelogenous leukemia AML. Blood ASH Annual Meeting Abstracts 106, Abstract 2729; 2005.
18. Lenth, R. V. Statistical power calculations. J. Anim. Sci. 85:E24-29; 2007.
19. Li, X.; Lu, J. Y.; Zhao, L. Q.; Wang, X. Q.; Liu, G. L.; Liu, Z.; et al. Overexpression of ETS2 in human esophageal squamous cell carcinoma. World J. Gastroenterol. 9:205-208; 2003.
20. Linding, R.; Russell, R. B.; Neduva, V.; Gibson, T. J. GlobPlot: Exploring protein sequences for globularity and disorder. Nucl. Acids Res. 31:3701-3708; 2003.
21. Miller, S. A.; Dykes, D. D.; Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl. Acid Res. 16:1215; 1988.
22. Pande, P.; Chakravarti, N.; Soni, S.; Mathur, M.; Shukla, N. K.; Ralhan, R. ETS-1 expression in human oral squamous cell carcinoma: Potential prognostic implications. Cancer Detect. Prev. 24(Suppl. 1); 2000.
23. Papas, T. S.; Watson, D. K.; Sacchi, N.; et al. ETS family of genes in leukemia and Down syndrome. Am. J. Med. Genet. 7:251-261; 1990.
24. Rachidi, M.; Lopes, C. Mental retardation in Down syndrome: From gene dosage imbalance to molecular and cellular mechanisms. Neurosci. Res. 59:349-369; 2007.
25. Ramensky, V.; Pork, P.; Sunyaev, S. Human non-synonymous SNPs: Server and survey. Nucl. Acids Res. 30:3894-3900; 2002.
26. Sementchenko, V. I.; Watson, D. K. Ets target genes: Past, present and future. Oncogene 19:6533-6548; 2000.
27. Sumarsono, S. H.; Wilson, T. J.; Tymms, M. J.; et al. Down's syndrome-like skeletal abnormalities in Ets2 transgenic mice. Nature 379:534-538; 1996.
28. Turner, D. P.; Moussa, O.; Sauane, M.; Fisher, P. B.; Watson, D. K. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. Cancer Res. 67: 1618-1625; 2007.
29. Wolvetang, E. J.; Wilson, T. J.; Sanij, E.; Busciglio, J.; et al. ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway. Hum. Mol. Genet. 12:247-255; 2003.
30. Xu, Z.; Kerstann, K. F.; Sherman, S. L.; Chakravarti, A.; Feingold, E. A trisomic transmission disequilibrium test. Genet. Epidemiol. 26:125-131; 2004.
31. Yanai, I.; Benjamin, H.; Shmoish, M.; Chalifa-Caspi, V.; Shklar, M.; Ophir, R.; Bar-Even, A.; Horn-Saban, S.; Safran, M.; Domany, E.; Lancet, D.; Shmueli, O. Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics 21:650-659; 2005.
32. Yuan, H. Y.; Chiou, J. J.; Tseng, W. H.; Liu, C. H.; Liu, C. K.; Lin, Y. J.; et al. FASTSNP: An always uptodate and extendable service for SNP function analysis and prioritization. Nucl. Acids Res. 34:W635-641; 2006.
33. Yue, P.; Melamud, E.; Moult, J. SNPs3D: Candidate gene and SNP selection for association studies. BMC Bioinformatics 7:166; 2006.